272 related articles for article (PubMed ID: 17487359)
1. The effect of co-expression costimulatory molecule CD80 on uptake of antigen peptide-MHC class I-GFP complex by specific T cells.
Liu X; Zhang L; Zhang X; Yu H; Zhao X; Lu J; Qian G; Ge S
Int J Oncol; 2007 Jun; 30(6):1389-96. PubMed ID: 17487359
[TBL] [Abstract][Full Text] [Related]
2. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
3. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
[TBL] [Abstract][Full Text] [Related]
4. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
5. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
6. Expression of costimulatory molecules on human retinoblastoma cells Y-79: functional expression of CD40 and B7H1.
Usui Y; Okunuki Y; Hattori T; Takeuchi M; Kezuka T; Goto H; Usui M
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4607-13. PubMed ID: 17003458
[TBL] [Abstract][Full Text] [Related]
7. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens.
Chan RC; Xie Y
Oncol Rep; 2004 Aug; 12(2):435-42. PubMed ID: 15254713
[TBL] [Abstract][Full Text] [Related]
8. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
Hetttihewa LM
Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
[TBL] [Abstract][Full Text] [Related]
9. B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.
Katsanis E; Xu Z; Bausero MA; Dancisak BB; Gorden KB; Davis G; Gray GS; Orchard PJ; Blazar BR
Cancer Gene Ther; 1995 Mar; 2(1):39-46. PubMed ID: 7542553
[TBL] [Abstract][Full Text] [Related]
10. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
[TBL] [Abstract][Full Text] [Related]
11. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions.
Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P
Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C delta stimulates antigen presentation by Class II MHC in murine dendritic cells.
Majewski M; Bose TO; Sillé FC; Pollington AM; Fiebiger E; Boes M
Int Immunol; 2007 Jun; 19(6):719-32. PubMed ID: 17446207
[TBL] [Abstract][Full Text] [Related]
13. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
Thompson JA; Dissanayake SK; Ksander BR; Knutson KL; Disis ML; Ostrand-Rosenberg S
Cancer Res; 2006 Jan; 66(2):1147-54. PubMed ID: 16424052
[TBL] [Abstract][Full Text] [Related]
14. Optimal induction of effector but not memory antitumor cytotoxic T lymphocytes involves direct antigen presentation by the tumor cells.
Guilloux Y; Bai XF; Liu X; Zheng P; Liu Y
Cancer Res; 2001 Feb; 61(3):1107-12. PubMed ID: 11221840
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous expression of allogenic class II MHC and B7.1 (CD80) molecules in A20 B-lymphoma cell line enhances tumor immunogenicity.
Jang YJ; Nam SY; Kim MS; Seong RH; Park YS; Chung YH; Chung HY
Mol Cells; 2002 Feb; 13(1):130-6. PubMed ID: 11911464
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of the CD80 costimulatory molecule into ocular melanoma cells using a novel episomal vector.
Uno T; Chen PW; Murray TG; Podack ER; Ksander BR
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2531-9. PubMed ID: 9375572
[TBL] [Abstract][Full Text] [Related]
17. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
[TBL] [Abstract][Full Text] [Related]
18. Direct stimulation of naïve T cells by antigen-presenting cell vesicles.
Sprent J
Blood Cells Mol Dis; 2005; 35(1):17-20. PubMed ID: 15932799
[TBL] [Abstract][Full Text] [Related]
19. Direct mapping of MHC class II epitopes.
Milosevic S; Behrends U; Christoph H; Mautner J
J Immunol Methods; 2005 Nov; 306(1-2):28-39. PubMed ID: 16168435
[TBL] [Abstract][Full Text] [Related]
20. Quantitative aspects of T cell activation--peptide generation and editing by MHC class I molecules.
Stevanović S; Schild H
Semin Immunol; 1999 Dec; 11(6):375-84. PubMed ID: 10625591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]